Nayan J. Sarma

955 total citations
29 papers, 761 citations indexed

About

Nayan J. Sarma is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Nayan J. Sarma has authored 29 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Surgery. Recurrent topics in Nayan J. Sarma's work include Genomics and Chromatin Dynamics (7 papers), RNA Research and Splicing (7 papers) and MicroRNA in disease regulation (5 papers). Nayan J. Sarma is often cited by papers focused on Genomics and Chromatin Dynamics (7 papers), RNA Research and Splicing (7 papers) and MicroRNA in disease regulation (5 papers). Nayan J. Sarma collaborates with scholars based in United States, India and Canada. Nayan J. Sarma's co-authors include Venkataswarup Tiriveedhi, Thalachallour Mohanakumar, Nabeel R. Yaseen, William C. Chapman, Kristine A. Willis, Jeffrey S. Crippin, Akiko Takeda, George M. Santangelo, Vijay Subramanian and Sabarinathan Ramachandran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Nayan J. Sarma

28 papers receiving 749 citations

Peers

Nayan J. Sarma
Soheyla Saadi United States
Elizabeth H. Gray United Kingdom
Stella Chang United States
Mary A. Antonysamy United States
J. Bagley United States
Canan Kuscu United States
Yaling Dou United States
Allon Canaan United States
Soheyla Saadi United States
Nayan J. Sarma
Citations per year, relative to Nayan J. Sarma Nayan J. Sarma (= 1×) peers Soheyla Saadi

Countries citing papers authored by Nayan J. Sarma

Since Specialization
Citations

This map shows the geographic impact of Nayan J. Sarma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nayan J. Sarma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nayan J. Sarma more than expected).

Fields of papers citing papers by Nayan J. Sarma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nayan J. Sarma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nayan J. Sarma. The network helps show where Nayan J. Sarma may publish in the future.

Co-authorship network of co-authors of Nayan J. Sarma

This figure shows the co-authorship network connecting the top 25 collaborators of Nayan J. Sarma. A scholar is included among the top collaborators of Nayan J. Sarma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nayan J. Sarma. Nayan J. Sarma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarma, Nayan J. & Arindam Dey. (2024). Improvement of Long-Term Performance of Unpaved Road Constructed Over Marginalized Subsoil Using Geotextile Reinforcement. International Journal of Geosynthetics and Ground Engineering. 10(3).
2.
Xu, Zhongping, Deepak Nayak, Wei Yang, et al.. (2015). Dysregulated MicroRNA Expression and Chronic Lung Allograft Rejection in Recipients With Antibodies to Donor HLA. American Journal of Transplantation. 15(7). 1933–1947. 41 indexed citations
3.
Tiriveedhi, Venkataswarup, Gundumi A. Upadhya, Jianluo Jia, et al.. (2014). Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression. Transplant Immunology. 30(2-3). 93–98. 28 indexed citations
4.
Ramachandran, Sabarinathan, Haseeb Ilias Basha, Nayan J. Sarma, et al.. (2013). Hepatitis C Virus Induced miR200c Down Modulates FAP-1, a Negative Regulator of Src Signaling and Promotes Hepatic Fibrosis. PLoS ONE. 8(8). e70744–e70744. 42 indexed citations
5.
Angaswamy, Nataraju, Venkataswarup Tiriveedhi, Nayan J. Sarma, et al.. (2013). Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Human Immunology. 74(11). 1478–1485. 79 indexed citations
6.
Tiriveedhi, Venkataswarup, Nayan J. Sarma, Medhat Askar, et al.. (2013). Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: Clinical correlations. The Journal of Heart and Lung Transplantation. 32(8). 807–814. 67 indexed citations
7.
Sarma, Nayan J., Venkataswarup Tiriveedhi, & Thalachallour Mohanakumar. (2013). Detection of Antibodies to Self-Antigens (K-alpha 1 Tubulin, Collagen I, II, IV, and V, Myosin, and Vimentin) by Enzyme-Linked Immunosorbent Assay (ELISA). Methods in molecular biology. 1034. 335–341. 4 indexed citations
8.
Sarma, Nayan J. & Nabeel R. Yaseen. (2013). Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins. PLoS ONE. 8(6). e67032–e67032. 7 indexed citations
9.
Tiriveedhi, Venkataswarup, et al.. (2013). Anti-major histocompatibility complex–induced obliterative airway disease: Selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens. The Journal of Heart and Lung Transplantation. 32(7). 714–722. 10 indexed citations
10.
Sarma, Nayan J. & Kristine A. Willis. (2012). The new nucleoporin. Nucleus. 3(6). 508–515. 5 indexed citations
11.
Tiriveedhi, Venkataswarup, Nayan J. Sarma, & T. Mohanakumar. (2012). An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection. International Journal of Immunogenetics. 39(5). 373–380. 7 indexed citations
12.
Sarma, Nayan J., Venkataswarup Tiriveedhi, Nataraju Angaswamy, & T. Mohanakumar. (2012). Role of antibodies to self-antigens in chronic allograft rejection: Potential mechanism and therapeutic implications. Human Immunology. 73(12). 1275–1281. 11 indexed citations
13.
Sarma, Nayan J., Venkataswarup Tiriveedhi, Vijay Subramanian, et al.. (2012). Hepatitis C Virus Mediated Changes in miRNA-449a Modulates Inflammatory Biomarker YKL40 through Components of the NOTCH Signaling Pathway. PLoS ONE. 7(11). e50826–e50826. 54 indexed citations
14.
Sarma, Nayan J., et al.. (2011). The Nuclear Pore Complex Mediates Binding of the Mig1 Repressor to Target Promoters. PLoS ONE. 6(11). e27117–e27117. 25 indexed citations
15.
Sarma, Nayan J. & Nabeel R. Yaseen. (2011). Amino-terminal Enhancer of Split (AES) Interacts with the Oncoprotein NUP98-HOXA9 and Enhances Its Transforming Ability. Journal of Biological Chemistry. 286(45). 38989–39001. 11 indexed citations
16.
Tiriveedhi, Venkataswarup, et al.. (2011). Identification of HLA-A24-restricted CD8+ cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer–associated antigen. Human Immunology. 73(1). 11–16. 10 indexed citations
17.
Sarma, Nayan J., Akiko Takeda, & Nabeel R. Yaseen. (2010). Colony Forming Cell (CFC) Assay for Human Hematopoietic Cells. Journal of Visualized Experiments. 33 indexed citations
18.
Takeda, Akiko, et al.. (2010). Inhibition of CRM1-mediated Nuclear Export of Transcription Factors by Leukemogenic NUP98 Fusion Proteins. Journal of Biological Chemistry. 285(21). 16248–16257. 47 indexed citations
19.
Sarma, Nayan J., et al.. (2009). Dissection of the Transformation of Primary Human Hematopoietic Cells by the Oncogene NUP98-HOXA9. PLoS ONE. 4(8). e6719–e6719. 25 indexed citations
20.
Menon, Balaraj B., Nayan J. Sarma, Satish Pasula, et al.. (2005). Reverse recruitment: The Nup84 nuclear pore subcomplex mediates Rap1/Gcr1/Gcr2 transcriptional activation. Proceedings of the National Academy of Sciences. 102(16). 5749–5754. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026